Comparison of Skin dose Measurement Using Glass Dosimeter and Diode for Breast Cancer Patients
Young-Eun KO; Sung-Ho PARK; Byoung-Joon CHOI; Hee-Sun KIM; Young-Ju NOH.
Korean Journal of Medical Physics
; : 9-13, 2008.
Artículo en Ko | WPRIM | ID: wpr-203481
Documentos relacionados
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Application value of a new lesion positioning stickers in breast lesion surface localization.
Advancing community-academic partnerships to achieve breast health equity: Applying the community-based participatory model to build capacity for sustained impact.
[Whole-cycle management norms of bone health in breast cancer].
Tissue-resident FOLR2<sup>+</sup> macrophages associate with CD8<sup>+</sup> T cell infiltration in human breast cancer.
Use of immobilisation bra for daily setup of patients with pendulous breasts undergoing radiotherapy.
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?
Experiences of breast cancer survivors with exercise rehabilitation: qualitative systematic review and meta-synthesis.
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study.
Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.